BioSimulytics
BioSimulytics provides software that helps drug developers predict and control crystal formation to reduce delays and failure risk in drug development. The company combines quantum physics simulations, machine learning models, and high-performance cloud computing to model polymorphism and crystallization behavior. It operates as a B2B SaaS platform used by pharmaceutical R&D teams and contract research organizations. The platform aims to shorten development timelines from months to weeks and improve the success rate of new drug candidates.
BioSimulytics
BioSimulytics provides software that helps drug developers predict and control crystal formation to reduce delays and failure risk in drug development. The company combines quantum physics simulations, machine learning models, and high-performance cloud computing to model polymorphism and crystallization behavior. It operates as a B2B SaaS platform used by pharmaceutical R&D teams and contract research organizations. The platform aims to shorten development timelines from months to weeks and improve the success rate of new drug candidates.